NCT01234701

Brief Summary

The purpose of this multicenter study is to evaluate the agreement among expert radiologists in interpreting magnetic resonance images (MRI) assessing common primary liver tumours in non-cirrhotic patients.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2010

Geographic Reach
6 countries

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 3, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 4, 2010

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

May 28, 2012

Status Verified

May 1, 2012

Enrollment Period

1.6 years

First QC Date

November 3, 2010

Last Update Submit

May 25, 2012

Conditions

Keywords

LiverNeoplasmsMagnetic Resonance ImagingSurgeryPathology

Outcome Measures

Primary Outcomes (1)

  • Inter-observer agreement among expert radiologists in diagnosing primary liver tumors by Magnetic Resonance Imaging (MRI).

    Inter-observer agreement for categorical data will by assessed by the Fliess' kappa (good agreement \>0.7).

    December 2010

Secondary Outcomes (4)

  • Agreement of radiologists with the actual diagnosis of primary liver tumors assessed by Magnetic Resonance Imaging (MRI).

    December 2010

  • Differences in radiologist' certainty of diagnosis (CoD) among different tumor types.

    December 2010

  • Intra-class correlation coefficient among radiologists' Certainty of Diagnosis (CoD) in diagnosis primary liver tumors by Magnetic Resonant Imaging (MRI)

    December 2010

  • Investigate the diagnostic efficacy of radiologists' certainty of diagnosis (CoD) in accurately predicting primary liver tumors assessed by Magnetic Resonant Imaging (MRI)

    December 2010

Study Arms (1)

Primary liver tumors, non-cirrhotic

This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonance Imaging (MRI) and underwent resection for primary liver tumors.

Other: Non-invasive Magnetic Resonance Imaging (MRI)Procedure: Liver resectionOther: Histopathology diagnosis of resected liver specimen

Interventions

Conventional pre-operative MRI

Also known as: Magnetic Resonance Imaging
Primary liver tumors, non-cirrhotic

Hepatectomy with an intention to cure

Also known as: Hepatectomy = liver resection by open surgery.
Primary liver tumors, non-cirrhotic

Histopathology diagnosis by expert pathologist.

Also known as: Examination under the microscope.
Primary liver tumors, non-cirrhotic

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care clinics

You may qualify if:

  • Histopathological diagnosis of Hepatocellular Cancer (HCC), Adenoma and/or Focular nodular hyperplasia (FNH).
  • Patients that received a pre-operative Magnetic Resonance Imaging (MRI).
  • Patients that underwent liver resection with an intention to cure.
  • Patient over 18 years of age

You may not qualify if:

  • Other histopathological diagnosis such as cysts and hemangiomas.
  • Patient age less than 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02117-0825, United States

Location

St. Louis University, Liver Center

St Louis, Missouri, 63110-0250, United States

Location

University Hospital Strasbourg

Strasbourg, Cedex, 67098, France

Location

University Hospital Essen

Essen, 45147, Germany

Location

Auckland City Hospital

Auckland, Auckland, 9, New Zealand

Location

University Hospital Zurich, Department of Interventional and Diagnostic Radiology

Zurich, Canton of Zurich, 8091, Switzerland

Location

University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center

Zurich, Canton of Zurich, 8091, Switzerland

Location

The Leeds Teaching Hospitals NHS Trust

Leeds, LS9 7TF, United Kingdom

Location

University College London Hospitals NHS Foundation Trust

London, NW1 2PG, United Kingdom

Location

Imperial College, Hammersmith Hospital

London, W12 0HS, United Kingdom

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Magnetic Resonance SpectroscopyHepatectomy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Stefan Breitenstein, MD

    University Hospital Zurich, Department of Visceral and Transplant Surgery, Zurich, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2010

First Posted

November 4, 2010

Study Start

October 1, 2010

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

May 28, 2012

Record last verified: 2012-05

Locations